The HDAC inhibition activity of SFN has been shown to lead to an increase in the global and local histone acetylation status of a number of genes including tumor promoter genes such as human telomerase reverse transcriptase (hTERT) in breast cancer [18]. The gene discussed is SFN; the disease is breast cancer.